- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: SY-005
Total 3465 results
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.Suspended
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.Completed
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.CompletedType 2 Diabetes MellitusChina
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.Completed
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.Completed
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.Completed
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.Completed
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.Completed
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.Recruiting
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.Not yet recruiting
-
Seinda Pharmaceutical Guangzhou CorporationCompleted
-
University of ManitobaCanadian Institutes of Health Research (CIHR); Canadian Cancer Society (CCS); The Canadian Collaborative for Childhood Cannabinoid TherapeuticsNot yet recruitingCancer | Childhood Cancer
-
University of PennsylvaniaTerminatedRecurrent Clostridium Difficile InfectionUnited States
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.Completed
-
Revibe TechnologiesCompleted
-
Shouyao Holdings (Beijing) Co. LTDRecruitingNon-Small Cell Lung CancerChina
-
Shouyao Holdings (Beijing) Co. LTDRecruitingNon-Small Cell Lung Cancer | Solid Tumor | Medullary Thyroid CancerChina
-
Shouyao Holdings (Beijing) Co. LTDRecruitingAdvanced Solid TumorChina
-
Shouyao Holdings (Beijing) Co. LTDRecruitingAdvanced Solid TumorChina
-
Shouyao Holdings (Beijing) Co. LTDRecruiting
-
Lawson Health Research InstituteLondon Health Sciences Foundation; Ontario Ministry of Colleges and UniversitiesRecruitingCoronavirus Infection | SepsisCanada
-
EyeGene Inc.Novotech (Australia) Pty LimitedCompletedPrevention of Herpes Zoster (HZ)Australia
-
Shouyao Holdings (Beijing) Co. LTDNot yet recruiting
-
University of PennsylvaniaTerminatedSevere Clostridium Difficile Infection | Severe-Complicated/Fulminant Clostridium Difficile InfectionUnited States
-
Shouyao Holdings (Beijing) Co. LTDNot yet recruiting
-
EGEN, Inc.Terminated
-
Yabao Pharmaceutical GroupCompletedType 2 Diabetes Mellitus | Hyperglycaemia (Diabetic)China
-
Shouyao Holdings (Beijing) Co. LTDRecruitingNon-small Cell Lung CancerChina
-
Yabao Pharmaceutical GroupCompletedHealthy Volunteers | Hyperglycaemia (Diabetic)China
-
Syros PharmaceuticalsTerminatedBreast Cancer | Ovarian Cancer | Advanced Solid TumorsUnited States, Canada, France
-
EGEN, Inc.CompletedOvarian NeoplasmsUnited States
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedSkin Care | Skin | Skin CreamUnited States
-
PMG Pharm Co., LtdCompletedArthritisKorea, Republic of
-
Shouyao Holdings (Beijing) Co. LTDRecruitingNon-small-cell Lung CarcinomaChina
-
Azura OphthalmicsORA, Inc.Not yet recruitingDry Eye DiseaseUnited States
-
DermBiont, Inc.Suspended
-
Shouyao Holdings (Beijing) Co. LTDRecruitingAdvanced Solid TumorChina
-
ChemRar Research and Development Institute, LLCNot yet recruitingAnxiety Disorder Generalized
-
Kukje PharmaCompletedDry Eye SyndromesKorea, Republic of
-
Creabilis SACompletedPsoriasis VulgarisUnited States, United Kingdom
-
M.D. Anderson Cancer CenterActive, not recruitingPancreatic Ductal Adenocarcinoma | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma | KRAS NP_004976.2:p.G12DUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingDiffuse Large B-Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Mantle Cell Lymphoma | B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Transformed Non-Hodgkin LymphomaUnited States
-
DermBiont, Inc.Active, not recruiting
-
Hoth Therapeutics, Inc.Worldwide Clinical TrialsRecruitingAcneiform Eruption Due to Chemical | Xerosis Cutis | ParonychiaUnited States
-
Seelos Therapeutics, Inc.WithdrawnAlzheimer's DiseaseAustralia
-
Longbio PharmaRecruitingParoxysmal Nocturnal Hemoglobinuria (PNH)China
-
PfizerCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); ADC Therapeutics S.A.RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Blasts 5 Percent or More of Bone Marrow Nucleated Cells | CD22 PositiveUnited States
-
HvivoPrep Biopharm LimitedCompleted